Navigation Links
Forest Laboratories, Inc. Reports Fiscal Year 2009 Fourth Quarter Reported EPS of $0.31 Including $0.45 Per Share Charge Related to the Ongoing United States Attorney's Office Investigation
Date:4/21/2009

Earnings Per Share: $0.90 $0.76 $3.56 $3.46

Forest will host a conference call at 10:00 AM EDT today to discuss the results. The conference call will be webcast live beginning at 10:00 AM EDT on the Company's website at www.frx.com and also on the website www.streetevents.com. Please log on to either website at least fifteen minutes prior to the conference call as it may be necessary to download software to access the call. A replay of the conference call will be available until May 5, 2009 at both websites and also by dialing 1-800-642-1687 (US investors) or +1-706-645-9291 (international investors) Conference Call ID 92011267.

About Forest Laboratories

Forest Laboratories (NYSE: FRX) is a U.S.-based pharmaceutical company with a long track record of building partnerships and developing and marketing products that make a positive difference in people's lives. In addition to its well-established franchises in therapeutic areas of the central nervous and cardiovascular systems, Forest's current pipeline includes product candidates in all stages of development and across a wide range of therapeutic areas. The Company is headquartered in New York, NY. To learn more about Forest Laboratories, visit www.FRX.com.

Except for the historical information contained herein, this release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements involve a number of risks and uncertainties, including the difficulty of predicting FDA approvals, the acceptance and demand for new pharmaceutical products, the impact of competitive
'/>"/>

SOURCE Forest Laboratories, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11

Related medicine news :

1. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
2. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Commercial Availability of Savella(TM)
3. AUDIO from Medialink and Forest Pharmaceuticals: FDA Approves Lexapro for Major Depressive Disorder in Adolescents
4. Forest Laboratories, Inc. Announces FDA Approval of Lexapro(R) for the Treatment of Major Depressive Disorder in Adolescents
5. German Federal Patent Court Invalidates Wake Forest NPWT Patents Licensed to KCI
6. Wake Forest Baptist and Rivulet Connect New Operating Rooms with Interactive Video
7. Forest Laboratories, Inc. and Cypress Bioscience, Inc. Announce Revised Timing for Commercial Availability of Savella(TM)
8. Forest Laboratories, Inc. Provides Statement in Response to Complaint Filed by U.S. Government
9. United States Files Complaint Against Forest Laboratories for Allegedly Violating the False Claims Act
10. Old-Growth Forests Dying Off in U.S. West
11. Forest Laboratories, Inc. Reports Q309 Diluted Earnings Per Share of $0.62, Including $0.41 Per Share Charge for New Product Licensing Fees
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/4/2015)... ... August 04, 2015 , ... Buckeye Health Plan is reminding ... immunizations are covered for members under the Healthchek program . , “Many ... with their immunizations may not be allowed to attend when school begins in ...
(Date:8/4/2015)... (PRWEB) , ... August 04, 2015 , ... ... law firms and government entities, today announced that John Munro, a 15-year veteran ... Vice President of Managed Services Operations. , “I am thrilled to join Discovia ...
(Date:8/4/2015)... St. Louis, Missouri (PRWEB) , ... August 04, ... ... Automated Texting (IAT) solutions, today announced that Bruce McCalley joins its executive leadership ... 30-year track record of sales success at technology companies and expanding global markets ...
(Date:8/4/2015)... ... 04, 2015 , ... Mesothelioma researchers in Australia have some ... be a viable option. Surviving Mesothelioma has just posted an article on the ... at the University of New South Wales, peritoneal mesothelioma patients can ...
(Date:8/4/2015)... ... 04, 2015 , ... T.E.N., an information technology and security executive networking and ... Den and Jungle Lounge 2015, which will be held from 3-6:30 p.m. Aug. 5 ... eight emerging security vendors, known as “Gazelles,” will go head-to-head with the ISE® Lions, ...
Breaking Medicine News(10 mins):Health News:Buckeye Health Plan Reminds Parents to Keep Immunizations In Mind As School Year Kicks Off 2Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 2Health News:John Munro Joins eDiscovery Leader Discovia as Vice President of Managed Services Operations 3Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 2Health News:SanusEO Hires Healthcare Technology Executive Bruce McCalley As Senior Vice President of Sales & Marketing 3Health News:New Research Reveals Some Patients Experience Extended Mesothelioma Survival with Repeat Treatment, According to Surviving Mesothelioma 2Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 2Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 3Health News:T.E.N. Releases Pitch Schedule for The ISE® Lions Den & Jungle Lounge 2015 4
... increase in the death rates, from the combination of HIV ... of South Africa//. ,Western Cape tops for ... 2003 made TB is the biggest cause of mortality in ... people are to be warned about the dreaded conditions behind ...
... to a recent study, an old drug promises to slow ... systemic sclerosis//. ,About 3,00,000 Americans were found ... our system by hardening and thickening the skin and in ... organs. Nearly 80% of affected people have lung damaged more ...
... Germany have announced progress in their collaborative research ... treatment of hemophilia. ,Extensive in vitro ... lead molecules with promising pharmacological properties. ... make important progress in our collaboration with Baxter, ...
... by polio and as of now 15 people have ... mass vaccination campaign to fight polio. // This campaign ... permanent secretary in the health ministry. On the whole ... in the southern African country. Namibian President Hifikepunye Pohamba, ...
... // ,Pathology labs in the city have registered an increase ... ,Rajesh Bose (name changed) got an HIV test done last ... parents thought I was a flirt," said Bose. "But when I produced ... ,Not only men but prospective brides too are going in for HIV ...
... annual conference of the European Society of Human Reproduction ... //are comfortable with the thought of having twins via ... found that they were often not aware of the ... we have been alarmed by the large numbers of ...
Cached Medicine News:Health News:Advance in Program for Development of Non-Intravenous Therapy for Hemophilia 2Health News:Advance in Program for Development of Non-Intravenous Therapy for Hemophilia 3
(Date:8/4/2015)... Medical Services Holdings Limited ("Concord Medical", or the "Company") (NYSE: ... of the largest network of radiotherapy and diagnostic imaging centers ... release its financial results for the second quarter of 2015 ... Management will hold a conference call to discuss the results ... 2015 (8:00 p.m. in Beijing / ...
(Date:8/4/2015)... Md. , Aug. 4, 2015 ... drug-free over-the-counter ActiPatch® Musculoskeletal Pain Therapy medical devices, ... users of its ActiPatch 7-day trial device has ... journal Pain Management http://www.futuremedicine.com/doi/full/10.2217/PMT.15.35 .  ... the survey and submitted an assessment.  ...
(Date:8/4/2015)... Aug. 04, 2015 ... the addition of Jain PharmaBiotech,s new report ... to their offering. This report describes ... veterinary medicine and pharmaceuticals as well as improvement ... important in the application of biotechnology to manage ...
Breaking Medicine Technology:Concord Medical to Report Second Quarter 2015 Financial Results on August 17, 2015 2BioElectronics' Landmark 5,000+ Chronic Pain Patient Study Published in Pain Management Medical Journal 2Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 2Animal Biotechnology 2014-2024 - 2015 Technologies, Markets and Companies Analysis 3
... CSA Medical, Inc. announced today that New ... providing Spray Cryotherapy treatment for patients. Dr. Costas ... department of Cardiothoracic Surgery is performing this procedure. ... in the Department of Cardiothoracic Surgery at NYU ...
... 20 Despite Tylenol,s product recalls and plant closure, ... consumers, according to a research study released today. ... and build loyalty to them in the same way ... terms of warmth and competence – and these judgments ...
Cached Medicine Technology:CSA Medical, Inc. Announces 75th Customer 2Study of Brands Shows Tylenol Maintains Consumer Loyalty Despite Recent Quality Challenges 2
TG (Ab) RIA Thyroid Function 014-HD 27.1 Thyroglobulin...
Total T4 EIA Thyroid Function 025-BC-1007...
... anti-TPOn is a competitive radioimmunoassay for the ... ,(TPO) in human serum using the coated ... anti-TPOn BRAHMS employs ... thyroids. For the de-,termination of anti-TPO antibodies ...
Free T3 EIA Thyroid Function 025-BC-1006...
Medicine Products: